Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy
NCT ID: NCT01939210
Last Updated: 2018-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2010-02-28
2015-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy
NCT02170350
Stress Management Training in Patients Undergoing Radiation Therapy for Cancer
NCT00057733
Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress
NCT02988271
Using Meditation for Oncology Anxiety
NCT04312191
Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners
NCT02596490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To evaluate the influence of regular breathing cycles using breathing relaxation techniques on efficacy of the respiratory-gated treatment as measured by: (1) real-time position management (RPM) parameters; (2) end inspiration or expiration length; (3) changes in gate width.
SECONDARY OBJECTIVES:
I. To evaluate the effect of breathing relaxation techniques on: (1) psychosocial outcomes; (2) treatment compliance.
OUTLINE:
PHASE I: Patients and staff members complete structured interviews at baseline.
PHASE II: Patients are randomized to 1 of 2 arms.
ARM I: Patients participate in 3 50-minute breathing training sessions, including a psycho-educational component and meditation-based breathing training, over 10 days. Patients then undergo four dimensional computed tomography (4D-CT) on day 14 and undergo image-guided stereotactic body radiation therapy (SBRT) or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively.
ARM II: Patients receive standard care over 10 days. Patients then undergo 4D-CT on day 14 and undergo image-guided SBRT or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively.
After completion of study treatment, patients are followed up at 2 or 5 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (breathing training sessions)
Patients participate in 3 50-minute breathing training sessions, including a psycho-educational component and meditation-based breathing training, over 10 days. Patients then undergo 4D-CT on day 14 and undergo image-guided SBRT or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively.
Educational Intervention
Participate in breathing training sessions
Meditation Therapy
Participate in breathing training sessions
Questionnaire Administration
Ancillary studies
Arm II (control)
Patients receive standard care over 10 days. Patients then undergo 4D-CT on day 14 and undergo image-guided SBRT or standard radiation therapy 5 times a week for up to 5 fractions or 25 fractions, respectively.
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention
Participate in breathing training sessions
Meditation Therapy
Participate in breathing training sessions
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PHASE I - PATIENTS: Full comprehension of English language
* PHASE I - STAFF: All staff who have overseen the delivery of respiratory-gated radiotherapy for at least 6 months
* PHASE I - STAFF: Full comprehension of English language
* PHASE II: All patients with abdominal or lung tumors undergoing a respiratory gating simulation
* PHASE II: Karnofsky performance status \> 60%
* PHASE II: Life expectancy \> 3 months
* PHASE II: No prior radiotherapy to the abdomen/lung
* PHASE II: Full comprehension of English language
Exclusion Criteria
* PHASE I - STAFF: Inability to comprehend English language interview questions
* PHASE II: Karnofsky performance status \< 60%
* PHASE II: Prior radiotherapy to the abdomen/lung
* PHASE II: Evidence of progressive or untreated gross disease outside of the abdomen/lung
* PHASE II: Inability to comprehend English language breathing exercise instructions
* PHASE II: Concurrent diagnosis of a significant respiratory disorder which requires the use of oxygen
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Albert Einstein College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alyson Moadel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alyson Moadel
Role: PRINCIPAL_INVESTIGATOR
Albert Einstein College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albert Einstein College of Medicine
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2013-01127
Identifier Type: REGISTRY
Identifier Source: secondary_id
09-068
Identifier Type: -
Identifier Source: secondary_id
09-12-392
Identifier Type: OTHER
Identifier Source: secondary_id
09-12-392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.